Today news
About the same in other media
Pharma, healthcare top bets of fund managers in March
Reading now: 441
Fund managers bought shares of pharma and healthcare companies in March as they believe the domestic pharma market is expected to grow by 12-14% led by new product launches, exports, and strong growth in the chronic segment.
They were buyers in Aurobindo Pharma, Ajanta Pharma, Wockhardt, Glenmark Pharma and diagnostic companies like Dr Lal PathLabs and Vijaya Diagnostics.
They also purchased insurance stocks like SBI Life, HDFC Life, and ICICI Prudential Life Insurance after favourable guidelines on the surrender value of policies were announced by the insurance regulator IRDAI. Also, the recent removal of the age limit on availing of health insurance is seen as boosting the prospects of life insurance companies.
(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com
About this in other media
Apollo, Fortis, Max Healthcare share prices rise 42-84% in a year: Should you Buy, Sell or Hold? Here's what experts say livemint.com /6 months ago
ESG fund managers in US see worst quarterly outflows economictimes.indiatimes.com /6 months ago
Tata Mutual Fund changes fund manager for eight schemes economictimes.indiatimes.com /6 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
